Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,226 | $6,639 | $5,933 | $5,137 |
| - Cash | $85 | $69 | $22 | $55 |
| + Debt | $2,714 | $2,933 | $2,992 | $3,538 |
| Enterprise Value | $11,854 | $9,502 | $8,904 | $8,621 |
| Revenue | $5,373 | $4,801 | $4,349 | $4,015 |
| % Growth | 11.9% | 10.4% | 8.3% | – |
| Gross Profit | $2,233 | $1,983 | $1,753 | $1,703 |
| % Margin | 41.6% | 41.3% | 40.3% | 42.4% |
| EBITDA | $1,187 | $1,006 | $870 | $889 |
| % Margin | 22.1% | 20.9% | 20% | 22.1% |
| Net Income | $456 | $352 | $271 | $412 |
| % Margin | 8.5% | 7.3% | 6.2% | 10.3% |
| EPS Diluted | 4.46 | 3.47 | 2.7 | 4.11 |
| % Growth | 28.5% | 28.5% | -34.3% | – |
| Operating Cash Flow | $1,003 | $851 | $706 | $716 |
| Capital Expenditures | -$643 | -$583 | -$584 | -$551 |
| Free Cash Flow | $360 | $268 | $122 | $165 |